DOI: 10.1055/s-00000142

Frauenheilkunde up2date

LinksClose Window

References

Pivot X, Romieu G, Bonnefoi H et al.
PHARE trial results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer. ESMO-Congress 2012; Abstract LBA5: presented October 1; 2012.

Download Bibliographical Data

We do not assume any responsibility for the contents of the web pages of other providers.